Figure 6.

Cumulative incidence of clinical outcomes by predicted LVH-Net risk of cardiac amyloidosis and hypertrophic cardiomyopathy. Cumulative incidence of heart failure, atrial fibrillation, and mortality by tertiles of increasing predicted LVH-Net risk of A: cardiac amyloidosis and B: hypertrophic cardiomyopathy in the validation sample, excluding individuals with known cardiac amyloid and hypertrophic cardiomyopathy. At-risk counts for each tertile are shown below each plot. Error bars represent 95% confidence intervals.